Name
agdi2
Label
Alpha-Glucosidase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2))
Description

Participant taking ALPHA-GLUCOSIDASE INHIBITORS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Alpha-Glucosidase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,613 -
Yes - - 7 -
Unknown - - 460 -
Alpha-Glucosidase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,657 1,956 3,613
Yes 4 3 7
Unknown 200 260 460
Alpha-Glucosidase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,155 242 216 3,613
Yes 7 - - 7
Unknown 425 14 21 460